AI assistant
Sending…
Capstone Holding Corp. — Director's Dealing 2010
May 25, 2010
35323_dirs_2010-05-25_1f448666-4316-4cc2-90ed-450c3cefff02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Capstone Therapeutics Corp. (CAPS)
CIK: 0000887151
Period of Report: 2010-05-21
Reporting Person: Spiegel Robert J. (Director)
More from Capstone Holding Corp.
Interim / Quarterly Report
2026
May 20
Proxy Solicitation & Information Statement
2026
May 8
Annual Report
2026
May 7
Proxy Solicitation & Information Statement
2026
May 7
Regulatory Filings
2026
May 6
Regulatory Filings
2026
Apr 27
Major Shareholding Notification
2026
Apr 23
Annual Report
2026
Apr 17
Annual Report
2026
Apr 17
Regulatory Filings
2026
Apr 16